Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark. (2020)

First Author: Ali MS

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11657-020-00746-z

PubMed Identifier: 32483674

Publication URI: http://europepmc.org/abstract/MED/32483674

Type: Journal Article/Review

Volume: 15

Parent Publication: Archives of osteoporosis

Issue: 1